Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
Clinical trial NCT00520169 · COMPLETED
Trial details
- NCT number
- NCT00520169
- Sponsor
- Javelin Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2007-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.